Our overall finding, that cognition was not worse in participants with LRRK2/GBA PD than in those with only the LRRK2 variation, challenges cellular and clinical data suggesting convergent deleterious associations of dual LRRK2 and GBA variations. This evidence concerns the gene LRRK2 and Parkinson disease.